I teach doctors how to interpret test results—and the labels 'normal' and 'abnormal' often hide what matters most

JordanOkay, I've got a story for you: I teach doctors how to interpret test results—and the labels 'normal' and 'abnormal' often hide what matters most. Tell me what jumps out at you first.

Dr. LiangThe label "normal" doesn't hide anything because it describes the data, but "abnormal" hides the fact that V's swollen hands are a symptom, not a disease. You're teaching doctors to read the printout when they should be asking why the printout changed in the last hour. That distinction saves lives in the ER, not just in the office.

JordanV walked into that ER with swollen hands and a bigger heart on the X-ray, and the doctor still called it "worrying signs" instead of saying what it actually meant. The label did its job keeping things vague while V sat there breathing shallowly. Who really wins when we let a medical term stand in for a clear explanation?

Dr. LiangCalling those signs “worrying” isn’t hiding the truth; it’s accurately reflecting that the doctor didn’t have enough information to diagnose the cause right then. V’s chest tightness was a red flag, sure, but labeling every intermediate step as deceptive misses the point that medicine is a process of elimination, not a single announcement. You’re blaming the word choice for what is actually a gap in time and evidence.

JordanThat argument's leaning on something it hasn't actually proven.

Dr. LiangPicture someone whose blood pressure reads 150/95 during a routine checkup; calling that “high” doesn’t mean the doctor is being evasive, it means the body is under stress without a confirmed heart attack yet. You’re treating that momentary uncertainty like a cover-up when it’s actually the system working correctly to prevent premature conclusions. The real problem starts when we skip that caution phase entirely.

JordanA 150 systolic is a warning, not a verdict. But skipping the diagnosis leaves V paying the bill twice—once for the hospital stay, once for the confusion. Who profits from that delay?

Dr. LiangYou’re right that the cost of ambiguity falls squarely on the patient’s wallet, not the institution’s ledger. But attributing that expense to intentional profit ignores that diagnostic testing itself requires expensive equipment and specialized staff, which drives up the baseline price before any misinterpretation happens. The issue isn’t greed in the delay; it’s the high fixed cost of accurate cardiology.

JordanThe MRI machine costs millions upfront, so the baseline price tag is baked in no matter how fast the doctor works. But that doesn't explain why V's follow-up visit charges another three hundred dollars to confirm what his initial labs already suggested was off. Hospitals win big on repeat billing cycles, not on getting the first call right.

Dr. LiangBlaming hospitals for repeat visits is like accusing a bakery for selling bread twice because you forgot to pay for the first loaf. The second charge reflects the actual labor of confirming V’s cardiac status, not a trap to drain his account. Fixed costs drive the baseline price, not the billing cycle.

JordanThe bakery comparison misses that V has to return to get confirmation, which creates a natural revenue stream for the facility. Doctors lose out on clarity when they rely on generic labels, and patients pick up the tab for that lack of precision. We need better communication standards, not more billing cycles.

Dr. LiangBetter communication standards help, but they don’t erase the physical reality that confirming V’s heart enlargement takes actual specialist time and resources. The underlying trend isn’t hospital greed; it’s the unavoidable friction between complex diagnostics and immediate answers. Focus on improving that handoff rather than blaming the billing cycle for the biology.

JordanCalling the delay "unavoidable friction" lets the system off the hook while V pays the premium for every ambiguous label attached to his chest X-ray. Until doctors stop hiding behind the term "abnormal" to defer the real work, the patient remains the sole loser in a market where institutions never eat their own mistakes. That’s the gap I’m watching.